SCHEMBL4081261

SCHEMBL4081261

COCCc1ccc(OCC2CO2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.57
TP53 P04637 3/20 0.57
TSHR P16473 3/20 0.57
MAPT P10636 2/20 0.57
HPGD P15428 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
HIF1A Q16665 2/20 0.57
CYP1A2 P05177 1/20 0.57
PPARG P37231 1/20 0.57
TDP1 Q9NUW8 1/20 0.56
PKM P14618 2/20 0.54
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53
CYP3A4 P08684 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
DRD4 P21917 4/20 0.45
GLA P06280 1/20 0.44
NR3C1 P04150 1/20 0.43
ADRB2 P07550 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902039 1.00 ALDH1A1 (0.57) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL7950778 0.93 TP53 (0.50) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL11464933 0.90 ALDH1A1 (0.54) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL29151515 0.90 ALDH1A1 (0.62) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL3871705 0.88 TDP1 (0.66) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL732382 0.87 TDP1 (0.56) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL22754834 0.86 ALDH1A1 (0.50) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL11852793 0.86 ALDH1A1 (0.53) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL1680021 0.85 KMT2A (0.58) ALDH1A1TP53TSHRMAPTHPGD
SCHEMBL8981438 0.85 ALDH1A1 (0.58) ALDH1A1TP53TSHRMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115872880-A Novel crystal form of metoprolol and preparation method thereof 河北以岭医药研究院有限公司 2023-03-31 CN claimed
CN-111018724-B Metoprolol and preparation method thereof 江西美晶科技有限公司 2022-11-08 CN claimed
CN-113122057-A Quantum dot ink and preparation method of quantum dot film TCL集团股份有限公司 2021-07-16 CN claimed
CN-112645827-A Method for continuously synthesizing metoprolol and salt thereof 浙江普洛家园药业有限公司 2021-04-13 CN claimed
CN-111018724-A Metoprolol and preparation method thereof 江西美晶科技有限公司 2020-04-17 CN claimed
CN-102381995-B Preparation method of metoprolol YANGTZE RIVER PHARMACEUTICAL GROUP BEIJING HAIYAN PHARMACEUTICAL CO LTD 2015-04-15 CN claimed
CN-101607918-B Method for preparing metoprolol BEIJING DVENTUREPHARM TECHNOLOGY DEV CO LTD 2014-02-19 CN claimed
EP-1682081-A2 PROCESS FOR MANUFACTURE OF METOPROLOL AND SALTS THEREOF IPCA Laboratories Limited (IN) 2006-07-26 EP claimed
WO-2005046568-A2 PROCESS FOR MANUFACTURE OF METOPROLOL AND SALTS THEREOF IPCA LABORATORIES LIMITED (IN) 2005-05-26 WO claimed
US-20050107635-A1 Metoprolol manufacturing process IPCA LABORATORIES LIMITED (IN) 2005-05-19 US claimed
EP-0942899-B1 MANUFACTURING PROCESS OF METOPROLOL ASTRAZENECA AB (SE) 2003-03-12 EP claimed
US-6252113-B1 O-ETHERIFICATION OF P-(2-METHOXYETHYL)-PHENOL WITH AQUEOUS EPICHLOROHYDRIN, EVAPORATION OF EXCESS EPICHLOROHYDRIN, DISTILLATION, THEN AMINATION WITH ISOPROPYLAMINE TO YIELD METOPROLOL PRODUCT ASTRAZENECA AB (SE) 2001-06-26 US claimed
EP-0942899-A1 MANUFACTURING PROCESS OF METOPROLOL Astra Aktiebolag (SE) 1999-09-22 EP claimed
WO-1998022426-A1 NEW MANUFACTURING PROCESS OF METOPROLOL ASTRA AKTIEBOLAG (SE) 1998-05-28 WO claimed
US-5082969-A Industrial process for obtaining an aryloxypropanolamine ESTEVE QUIMICA, S.A. (ES) 1992-01-21 US claimed
US-4956284-A Process for producing 4-(2-methoxyethyl)-phenyl-glycidyl ether and/or metoprolol GIST-BROCADES N.V. (NL) 1990-09-11 US claimed
EP-0193228-B1 PROCESS FOR PRODUCING OF 4-(2-METHOXYETHYL)-PHENYLGLYCIDYL ETHER AND/OR METOPROLOL GIST-BROCADES N.V. (NL) 1989-11-02 EP claimed
EP-0193228-A1 Process for producing of 4-(2-methoxyethyl)-phenylglycidyl ether and/or metoprolol GIST-BROCADES N.V. (NL) 1986-09-03 EP claimed
US-20240034832-A1 CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, AND OPTICAL DEVICE DAICEL CORPORATION (JP) 2024-02-01 US disclosed
US-3956335-A HYPERTENSIVE AGENTS CIBA-GEIGY CORPORATION (US) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107635-A1 Metoprolol manufacturing process ADRB1, ADRB2, POR ALDH1A1 535/4885TP53 4540/4885TSHR 2571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.